Cart0Item(s)

You have no items in your shopping cart.

Product was successfully added to your shopping cart.
Subscribe to RSS Feed

Medicines-Veropharm-PharmSintez-Vifor-Canada Peptides

   

11 Item(s)

  1. Aprotex (Aprotinin) 10000 ATpU 10 vials

    Aprotex (Aprotinin) 10000 ATpU 10 vials Hematotropics

    $35.20
  2. Octreotide ampoules 0.01% 1ml vial, 0.005% 1ml 5 vials, 0.01% 1ml 5 vials, 0.005% 1ml 10 vials, 0.03% 1ml 10 vials,

    Octreotide ampoules Hormones 0.01% 1ml vial, 0.005% 1ml 5 vials, 0.01% 1ml 5 vials, 0.005% 1ml 10 vials, 0.03% 1ml 10 vials,

    $15.40
  3. Buserelin-depo 3.75mg ampoule

    Buserelin-depo 3.75mg ampoule Hormones

    $205.70
  4. Octreotide-depo 30mg lyophilisate

    Octreotide-depo 30mg lyophilisate Hormones

  5. Ginos (ginkgo biloba) 40mg 30 tablets

    Ginos (ginkgo biloba) 40mg 30 tablets Anti-aggregants

    $11.00
  6. Maltofer (Iron (III) hydroxide polymaltose) tablets, drops 5% 30ml drops, 100mg 30 tablets,

    Maltofer (Iron (III) hydroxide polymaltose) tablets, drops Hematotropics 5% 30ml drops, 100mg 30 tablets,

    $23.10
  7. Maltofer (Iron (III) hydroxide polymaltose) 50mg/ml 2ml 5 vials

    Maltofer (Iron (III) hydroxide polymaltose) 50mg/ml 2ml 5 vials Hematotropics

    $53.90
  8. Bi-Xikam (Meloxicam) 15mg 20 tablets

    Bi-Xikam (Meloxicam) 15mg 20 tablets Oxicams

    $14.30
  9. PT-141 Canada Peptides 2 mg x 1 vial

    The innovative product PT 141 from Canada Peptides will help you increase potency in men and sexual desire in women, this peptide is good because it works for everyone without exception, without having side effects.

    $29.70
  10. Cellex solution for subcutaneous injection 0.1 mg /ml 1ml ampoule, 5 pcs.

    Cerebrovascular diseases: - acute disorders of cerebral circulation in the acute and early rehabilitation period of the course of the disease as part of complex therapy.

    $192.50
  11. New

    Duphaston Tablet 10mg 20-28

    Duphaston tablets 10mg contain dydrogesterone, a synthetic progesterone, used to treat a variety of conditions resulting from a lack of endogenous (naturally produced) progesterone, including menstrual disorders and endometriosis, and for hormone replacement therapy (HRT) and transgender hormone therapy.

   

11 Item(s)